Novartis gains FDA approval for Afinitor®
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets…
5 May 2011 | By Novartis
Novartis announced today that the FDA approved Afinitor® (everolimus) tablets for the treatment of progressive neuroendocrine tumors of pancreatic origin (PNET)...